PDS Biotechnology Corporation PDSB

NAS: PDSB | ISIN: US70465T1079 26/04/2024

3,270 USD (+0,31%)

(+0,31%) 26/04/2024

Grafiek PDS Biotechnology Corporation

Grafiek PDS Biotechnology Corporation

1 dag1d 0,31%
1 week1w 9,36%
1 maand1m -15,06%
3 maanden3m -44,48%
6 maanden6m -18,66%
1 jaar1j -46,22%
5 jaar5j -47,85%

PDS Biotechnology Corporation in het nieuws

Toon enkel gratis nieuws

18 maart 2021 · PDS Biotech Reports Financial Results for the Year Ended December 31, 2020 and Provides Business Update · Persbericht

8 maart 2021 · PDS Biotechnology Announces Conference Call and Webcast for Fourth Quarter and Full Year 2020 Financial Results · Persbericht

3 maart 2021 · PDS Biotech Announces Presentations in Upcoming Healthcare Investor Conferences · Persbericht

22 februari 2021 · PDS Biotech and Farmacore Announce Blanver to Join Consortium to Commercialize Novel Versamune®-Based T-Cell Inducing COVID-19 Vaccine · Persbericht

14 januari 2021 · PDS Biotech Releases White Paper Detailing the Potential of the Versamune® Platform in Overcoming a Major Limitation of Immuno-Oncology · Persbericht

6 januari 2021 · PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

5 januari 2021 · PDS Biotech Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference · Persbericht

Profiel PDS Biotechnology Corporation

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.pdsbiotech.com

Hoofdzetel: Florham Park, New Jersey Verenigde Staten

CEO: Frank Bedu-Addo

Werknemers: 26

Aandelen PDS Biotechnology Corporation

Beurswaarde: 119,94 miljoen USD

Effecten: 36,68 miljoen

Beta: 2,92

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe